Statewide
Kentucky Board of Emergency Medical Services
Drugs and doses68
A–C Acetaminophen, Adenosine, Albuterol, Alteplase, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate, Cana, Cefazolin11
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 500–1000 mg | PO | not captured | standing | pages 79, 148 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | pages 79, 148 |
| Other | adult | 325 mg | PO | not captured | standing | page 278 |
| Other | peds | 15 mg/kg | PO/PR | not captured | standing | page 148 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | page 67 |
| Other | adult | 6 mg | IV | not captured | standing | page 69 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 128 |
| SVT | adult | 6 mg | IV | not captured | standing | page 295 |
| SVT | peds | 0.1–0.2 mg/kg | IV | not captured | standing | page 295 |
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | pages 67, 69, 128, 295 |
| Narrow-complex tachycardia | peds | 0.1–0.2 mg/kg | IV | not captured | standing | pages 67, 69, 128, 295 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2–8 puff | MDI | not captured | standing | pages 74, 134 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 74, 134, 135, 296 |
| Asthma / bronchospasm | peds | 0.05–0.15 mg/kg | NEB | not captured | standing | pages 74, 134, 135, 296 |
| Asthma / bronchospasm | peds | 2 puff | MDI | not captured | standing | pages 74, 134 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 296 |
| Other | peds | 0.01–0.03 mL/kg | NEB | not captured | standing | page 296 |
Alteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 100 mg | IV | not captured | standing | page 350 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | pages 69, 281, 297 |
| Other | adult | 300 mg | IV | not captured | standing | page 297 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 63, 124, 125 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 124 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 59 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | pages 65, 66, 126, 127, 299, 300 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | pages 65, 66, 126, 127, 299, 300 |
| Organophosphate poisoning | adult | 1–2 mg | IV | not captured | standing | pages 86, 91, 92, 144, 401, 409, 421 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV | not captured | standing | pages 86, 91, 92, 144, 401, 409, 421 |
| Other | adult | 1–2 mg | IV | not captured | standing | pages 401, 409 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 126 |
| Other | peds | 0.02 mg/kg | IV | not captured | standing | pages 401, 409 |
| Other | peds | 0.04 mg/kg | IV | not captured | standing | pages 402, 409 |
| Other | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 144 |
| Other | peds | 0.05–0.1 mg/kg | IV/IM/ET | not captured | standing | page 144 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 g | IV | not captured | standing | pages 86, 142, 301, 424 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV | not captured | standing | pages 86, 142, 301, 424 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | pages 301, 424 |
| Other | adult | 1–2 g | IV | not captured | standing | page 86 |
| Other | adult | 5–10 mL | IV | not captured | standing | page 424 |
| Other | peds | 0.1–0.2 mL | IV | not captured | standing | page 424 |
| Other | peds | 20 mg/kg | IV | not captured | standing | pages 301, 424 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 301 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 0.5 mL | SQ | not captured | standing | page 423 |
| Burns | adult | 10–30 mL | IV | not captured | standing | page 423 |
| Burns | peds | 0.2–0.3 mL/kg | IV | not captured | standing | page 423 |
| Other | adult | 2–4 mg/kg | IV | not captured | standing | page 301 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 301 |
Cana
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IM | not captured | standing | pages 333, 387 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | pages 196, 302 |
| Trauma / hemorrhage | peds | 35 mg/kg | IV | not captured | standing | pages 196, 302 |
D–F Dexamethasone, Dextrose, Diazepam, Diazoxide, Diltiazem, Diphenhydramine, Dobutamine, Dopamine, Droperidol, Epinephrine, Etomidate, Famotidine, Fentanyl, Furosemide14
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–100 mg/kg | IV | not captured | standing | page 303 |
| Other | peds | 0.25–1 mg/kg | IV | not captured | standing | page 303 |
| Other | peds | 0.25–1 mg/kg | IO/IM | not captured | standing | page 303 |
| Other | peds | 1 mg | not captured | not captured | standing | pages 112, 161 |
| Other | peds | 2 mg | not captured | not captured | standing | pages 112, 161 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 25 g | IV | not captured | standing | pages 112, 161 |
| Adrenal crisis | peds | 2.5 mL/kg | IV | not captured | standing | pages 112, 161 |
| Hypoglycemia | adult | 10–25 g | IV/IO | not captured | standing | page 75 |
| Hypoglycemia | adult | 12.5–25 g | IV/IO | not captured | standing | pages 75, 136, 304 |
| Hypoglycemia | peds | 0.25 g/kg | IV | not captured | standing | page 136 |
| Hypoglycemia | peds | 0.25 g/kg | IV | not captured | standing | page 136 |
| Hypoglycemia | peds | 0.25 g/kg | IV | not captured | standing | page 136 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV/IO | not captured | standing | pages 75, 136, 304 |
| Other | adult | 12.5–25 g | IV | not captured | standing | page 304 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | page 304 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IM | not captured | standing | pages 91, 92 |
| Other | adult | 10 mg | IM | not captured | standing | page 90 |
| Other | adult | 5 mg | IV | not captured | standing | page 67 |
| Other | peds | 0.2 mg/kg | IV | not captured | standing | page 147 |
| Procedural sedation | adult | 5–15 mg | IV | not captured | standing | page 305 |
| Seizure | adult | 5 mg | IV | not captured | standing | pages 96, 305 |
| Seizure | adult | 5–10 mg | IV | not captured | standing | pages 67, 96, 147, 305 |
| Seizure | adult | 5–10 mg | IV | not captured | standing | page 305 |
| Seizure | peds | 0.2–0.3 mg/kg | IV | not captured | standing | pages 67, 96, 147, 305 |
| Seizure | peds | 0.2–0.3 mg/kg | IV | not captured | standing | pages 96, 305 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 305 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 305 |
Diazoxide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg/kg | IV | not captured | standing | page 306 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 306 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.2 mg/kg | IV | not captured | standing | page 53 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 307 |
| Other | adult | 5–15 mg | not captured | not captured | standing | page 307 |
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV | not captured | standing | page 307 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/PO | not captured | standing | pages 73, 133, 308 |
| Allergic reaction | peds | 1 mg/kg | IV/PO | not captured | standing | pages 73, 133, 308 |
| Dystonic reaction | adult | 50 mg | IV/IM | not captured | standing | pages 80, 86, 308 |
| Other | adult | 25–50 mg | IV/IM | not captured | standing | page 308 |
| Other | adult | 25–50 mg | PO | not captured | standing | page 308 |
| Other | adult | 25–50 mg | IV | not captured | standing | page 86 |
| Other | adult | 25–50 mg | IV/PO | not captured | standing | pages 73, 133 |
| Other | adult | 25–50 mg | IV | not captured | standing | page 278 |
| Other | adult | 50 mg | IV/IM | not captured | standing | page 80 |
| Other | peds | 1 mg/kg | IV/PO | not captured | standing | pages 73, 133 |
| Other | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 308 |
| Other | peds | 1–2 mg/kg | IO | not captured | standing | page 308 |
Dobutamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 25 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–10 mcg/kg | IV | not captured | standing | pages 65, 66 |
| Hypotension / shock | adult | 2–20 mcg/kg | IV | not captured | standing | pages 163, 166, 309 |
| Hypotension / shock | peds | 2–20 mcg/kg | IV | not captured | standing | pages 163, 166, 309 |
| Other | adult | 2–10 mcg/kg | IV | not captured | standing | page 65 |
| Other | adult | 2–20 mcg/kg | IV | not captured | standing | page 309 |
| Other | adult | 2–5 mcg/kg | IV | not captured | standing | page 278 |
| Other | peds | 2–20 mcg/kg | IV | not captured | standing | page 309 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV | not captured | standing | pages 35, 39 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | pages 35, 39 |
| Other | adult | 5 mg | IM | not captured | standing | pages 35, 39 |
| Other | adult | 5–10 mg | IV | not captured | standing | page 310 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 72, 132 |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 72, 132 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 72, 132 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 72, 132 |
| Bradycardia | adult | 2–10 mcg | IV | not captured | standing | pages 65, 66 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 126 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 62, 123, 124, 125 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 62 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 62, 123, 124, 125 |
| Hypotension / shock | adult | 1–2 mL | IV | not captured | standing | pages 131, 163, 166 |
| Hypotension / shock | peds | 1–2 mL | IV | not captured | standing | pages 131, 163, 166 |
| Neonatal resuscitation | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 122 |
| Neonatal resuscitation | peds | 0.03 mg/kg | ET | not captured | standing | page 122 |
| Other | adult | 0.05–0.3 mcg/kg | IV | not captured | standing | page 163 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | page 240 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 40 mg | IV/PO | not captured | standing | pages 73, 133 |
| Allergic reaction | peds | 0.25 mg/kg | IV/PO | not captured | standing | pages 73, 133 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mcg/kg (max 100 mcg) | IV/IM/IN | every 5 minutes up to a total of 200 mcg | standing | pages 83, 140 |
| Other | adult | 25 mcg | IV | q5 minutes | standing | page 178 |
| Other | adult | 25–50 mcg | IV/IO/IN | q5 min up to 100 mcg total | standing | page 81 |
| Other | adult | 25–50 mcg (max 150 mcg) | IV | not captured | standing | page 312 |
| Other | peds | 0.5 mcg/kg | IV | not captured | standing | page 312 |
| Other | peds | 0.5–1 mcg/kg (max 100 mcg) | IV/IM/IN | every 5 minutes up to a total of 200 mcg | standing | pages 83, 140 |
| Mild to moderate pain | adult | 25–50 mcg | IV/IM/IN | not captured | standing | pages 60, 81, 83, 140 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg | IV/IM/IN | not captured | standing | pages 60, 81, 83, 140 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.5–1 mg/kg | IV | not captured | standing | page 313 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 313 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 313 |
G–L Glucagon, Heparin, Hydrocortisone, Hydroxocobalamin, Ibuprofen, Insulin, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam12
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–5 mg | IV/IM/SQ | not captured | standing | pages 65, 86, 112, 161 |
| Hypoglycemia | adult | 0.5–1 mg | IM/SQ | not captured | standing | pages 75, 136, 314 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 75 |
| Other | adult | 0.5–1 mg | IV/IM/SQ | not captured | standing | page 314 |
| Other | adult | 1 mg | SQ | not captured | standing | page 75 |
| Other | adult | 2–5 mg | IV | not captured | standing | page 65 |
| Other | adult | 2–5 mg | IM/SQ | not captured | standing | pages 65, 86 |
| Other | peds | 1 mg | IM/SQ | not captured | standing | page 136 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 80 unit/kg | IV | not captured | standing | page 317 |
| Other | adult | 80 unit/kg | IV | not captured | standing | page 317 |
| Other | adult | 80 unit/kg | IV | not captured | standing | page 317 |
| Other | adult | 80 unit/kg | IV | not captured | standing | page 317 |
| Other | peds | 50 unit/kg | IV | not captured | standing | page 317 |
| Other | peds | 50 unit/kg | IV | not captured | standing | page 317 |
| Other | peds | 50 unit/kg | IV | not captured | standing | page 317 |
| Other | peds | 50 unit/kg | IV | not captured | standing | page 317 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Other | adult | 100 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Other | peds | 100 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Other | peds | 25 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Other | peds | 50 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 87, 143, 409 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | pages 87, 143, 409 |
| Other | adult | 5 g | IV | not captured | standing | page 87 |
| Other | adult | 5 g | IV | not captured | standing | page 318 |
| Other | peds | 70 mg/kg | IV | not captured | standing | page 318 |
| Other | peds | 70 mg/kg | IV | not captured | standing | page 143 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–800 mg | PO | not captured | standing | pages 79, 148 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | pages 79, 148 |
| Mild to moderate pain | adult | 400–800 mg | PO | not captured | standing | pages 82, 139 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 82, 139 |
Insulin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 10–25 unit | IV | not captured | standing | page 319 |
| Hyperkalemia | peds | 0.1–0.2 unit/kg | IV | not captured | standing | page 319 |
| Other | peds | 0.1–0.2 unit/kg | IV/IM | not captured | standing | page 319 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2–3 puff | MDI | not captured | standing | page 320 |
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | pages 74, 134, 135, 320 |
| Asthma / bronchospasm | peds | 1–2 puff | MDI | not captured | standing | page 320 |
| Asthma / bronchospasm | peds | 250 mcg | NEB | not captured | standing | pages 74, 134, 135, 320 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg/kg | IV | every 20 min as needed | standing | page 244 |
| Other | adult | 1–2 mg/kg | IV | not captured | standing | page 244 |
| Other | adult | 1.5 mg/kg | IV | not captured | standing | pages 37, 39 |
| Severe pain | adult | 0.15 mg/kg | IV | not captured | standing | pages 83, 140 |
| Severe pain | peds | 0.15 mg/kg | IV | not captured | standing | pages 83, 140 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15–30 mg | IV | not captured | standing | page 322 |
| Other | adult | 30–60 mg | IM | not captured | standing | page 322 |
| Other | peds | 0.5 mg/kg | IV | not captured | standing | page 140 |
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | pages 83, 140 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | pages 83, 140 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | pages 83, 140 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV | not captured | standing | page 290 |
| Other | adult | 20 mg | IV | not captured | standing | pages 97, 290 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 124, 323 |
| Other | adult | 1.5 mg/kg | IV | not captured | standing | page 323 |
| Other | adult | 2 mL | IO | not captured | standing | page 266 |
| Other | adult | 20–50 mg | IO | not captured | standing | page 268 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 266 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 124, 323 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 323 |
| Mild to moderate pain | adult | 2 mL | IO | not captured | standing | pages 266, 268 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | pages 266, 268 |
| VF / pulseless VT | peds | 1 mg/kg | IV | not captured | standing | page 124 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IV | not captured | standing | page 65 |
| Other | adult | 2–4 mg | IV/IM | not captured | standing | pages 91, 92 |
| Other | adult | 2 mg | IM | not captured | standing | page 65 |
| Other | adult | 2–4 mg | IV | not captured | standing | page 324 |
| Other | peds | 0.05–0.2 mg/kg | IV/IO | not captured | standing | page 324 |
| Procedural sedation | adult | 0.05 mg/kg | IV | not captured | standing | page 324 |
| Procedural sedation | adult | 1 mg | IV/IM | not captured | standing | page 65 |
| Seizure | adult | 4 mg | IV/IO | not captured | standing | pages 96, 147 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 96, 147 |
M–O Magnesium Sulfate, Mannitol, Methylene Blue, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 74 |
| Asthma / bronchospasm | peds | 2 g | IV | not captured | standing | page 74 |
| Other | adult | 1–4 g | IV | not captured | standing | page 325 |
| Other | adult | 2 g | IV | not captured | standing | page 284 |
| Other | adult | 4–6 g | IV | not captured | standing | page 284 |
| Other | peds | 4 g | IV | not captured | standing | page 96 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | pages 124, 325 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV/IO | not captured | standing | pages 124, 325 |
Mannitol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 g/kg | IV | not captured | standing | page 326 |
| Other | adult | 0.5 g/kg | IV | not captured | standing | page 326 |
| Other | adult | 0.5 g/kg | IV | not captured | standing | page 326 |
| Other | adult | 12.5 g | IV | not captured | standing | page 278 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | page 326 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | page 326 |
| Other | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 326 |
Methylene Blue
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg/kg | IV | not captured | standing | pages 397, 416 |
| Other | adult | 1–2 mg/kg | IV | not captured | standing | page 397 |
| Other | peds | 1–2 mg/kg | IV | not captured | standing | pages 397, 416 |
| Other | peds | 1–2 mg/kg | IV | not captured | standing | page 397 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Allergic reaction | adult | 125 mg | IV | not captured | standing | pages 73, 133 |
| Allergic reaction | peds | 1 mg/kg | IV | not captured | standing | pages 73, 133 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | pages 74, 135 |
| Asthma / bronchospasm | peds | 1 mg/kg | IV | not captured | standing | pages 74, 135 |
| Other | peds | 125 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Other | peds | 25 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
| Other | peds | 50 mg | IV/IO/IM | not captured | standing | pages 112, 161 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | pages 68, 327 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV | not captured | standing | pages 35, 39 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | pages 35, 39 |
| Other | adult | 5 mg | IV | not captured | standing | pages 37, 39 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 96 |
| Other | peds | 5 mg | IM | not captured | standing | pages 37, 39 |
| Procedural sedation | adult | 2.5 mg | IV | not captured | standing | page 65 |
| RSI induction | peds | 0.05–0.1 mg/kg | IV | not captured | standing | page 328 |
| RSI induction | peds | 0.1 mg/kg | IV | not captured | standing | page 328 |
| Seizure | adult | 10 mg | IM | not captured | standing | pages 91, 92, 96 |
| Seizure | peds | 5 mg | IM | not captured | standing | pages 91, 92, 96 |
| Seizure | peds | 5 mg | IV/IO | not captured | standing | page 96 |
| Narrow-complex tachycardia | adult | 2.5 mg | IV | not captured | standing | page 67 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–3 mg (max 10 mg) | IV/IM/SQ | every 5 minutes titrated to maximum of 10 mg | standing | page 329 |
| Other | adult | 4–8 mg | IV/IM | every 10 minutes to a total of 15 mg titrated to pain and SBP>90 | standing | pages 83, 140 |
| Other | adult | 4–8 mg | IV/IO | q10 min up to 10 mg total | standing | page 81 |
| Other | peds | 0.1–0.2 mg/kg (max 5 mg) | IV/IM/SQ | every 5 minutes titrated to maximum of 5 mg | standing | page 329 |
| Other | peds | 0.1 mg/kg | IV/IM | every 10 minutes to a total of 15 mg titrated to pain and SBP>90 | standing | pages 83, 140 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 138 |
| Mild to moderate pain | adult | 4 mg | IV | not captured | standing | pages 60, 81, 83, 138, 140, 329 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV | not captured | standing | pages 60, 81, 83, 138, 140, 329 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IM/SQ | not captured | standing | pages 86, 110, 142, 330 |
| Opioid overdose | adult | 2–4 mg | IN | not captured | standing | pages 85, 86, 110, 141, 142, 330 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 85, 86, 110, 141, 142, 330 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IM/SQ | not captured | standing | pages 86, 110, 142, 330 |
| Other | adult | 0.4–2 mg | IV/IM/SQ/ET | not captured | standing | page 330 |
| Other | adult | 0.4 mg | IV | not captured | standing | pages 83, 140 |
| Other | adult | 0.4 mg | not captured | not captured | standing | page 330 |
| Other | adult | 0.4–2 mg | IV/IM/SQ | not captured | standing | page 86 |
| Other | peds | 0.1 mg/kg | IV/IM/SQ/ET | not captured | standing | page 330 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 141, 142 |
| Other | peds | 2 mg | IN | not captured | standing | pages 110, 151 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.3–0.4 mg | SL | not captured | standing | page 335 |
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 59, 60 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 70, 335 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 335 |
| Other | adult | 0.8 mg | SL | not captured | standing | page 70 |
| Other | adult | 1 inch | TOP | not captured | standing | page 336 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 0.05–0.5 mcg/kg | IV | not captured | standing | pages 163, 166, 338, 340 |
| Other | adult | 0.05–0.5 mcg/kg | IV | not captured | standing | page 163 |
| Other | adult | 2–30 mcg | IV | not captured | standing | pages 338, 340 |
| Other | peds | 0.05–0.5 mcg/kg | IV | not captured | standing | page 163 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | page 339 |
| Nausea / vomiting | adult | 4–8 mg | IV/PO | not captured | standing | pages 73, 133, 149 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/PO | not captured | standing | pages 73, 133, 149 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | page 149 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | page 339 |
| Nausea / vomiting | peds | 2 mg | PO | not captured | standing | page 149 |
| Other | adult | 4–8 mg | IV/PO | not captured | standing | pages 73, 133 |
| Other | peds | 0.1 mg/kg | IV/PO | not captured | standing | pages 73, 133 |
P–R Pralidoxime, Prednisone, Procainamide, Prochlorperazine, Promethazine, Proparacaine, Protamine, Pyridoxine, Rocuronium9
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1–2 g | IV | not captured | standing | pages 86, 91, 92, 142, 144, 343, 402, 409, 420 |
| Organophosphate poisoning | peds | 20–40 mg/kg | IV | not captured | standing | pages 86, 91, 92, 142, 144, 343, 402, 409, 420 |
| Other | adult | 1 g | IV | not captured | standing | pages 402, 409 |
| Other | adult | 1–2 g | IV | not captured | standing | pages 86, 91, 92 |
| Other | adult | 1–2 g | IV | not captured | standing | page 343 |
| Other | peds | 20–40 mg/kg | IV | not captured | standing | page 343 |
| Other | peds | 20–40 mg/kg | IV | not captured | standing | pages 402, 409 |
| Other | peds | 25–50 mg/kg | IV/IM | not captured | standing | pages 142, 144 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 60 mg | PO | not captured | standing | pages 74, 135 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20–30 mg | IV | not captured | standing | page 344 |
| Other | adult | 20–50 mg | IV | not captured | standing | pages 69, 344 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 2.5 mg | IV | not captured | standing | pages 80, 86 |
| Nausea / vomiting | adult | 5 mg | IM | not captured | standing | pages 80, 86 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV | not captured | standing | page 80 |
| Nausea / vomiting | adult | 12.5 mg | IM | not captured | standing | page 80 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | OPH | not captured | standing | page 191 |
| Other | adult | 1–2 drop | OPH | not captured | standing | page 191 |
Protamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IV | not captured | standing | page 317 |
| Other | adult | 1 mg | IV | not captured | standing | page 317 |
| Other | peds | 1 mg | IV | not captured | standing | page 317 |
Pyridoxine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25 mg/kg | IV | not captured | standing | pages 406, 425 |
| Other | peds | 25 mg/kg | IV | not captured | standing | pages 406, 425 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI paralysis | adult | 1.2 mg/kg | IV | not captured | standing | page 240 |
S–Z Sodium Bicarbonate, Sodium Nitrite, Sotalol, Streptokinase, Succinylcholine, Terbutaline, Tetracaine, Thiamine, Tissue Plasminogen Activator, Tranexamic Acid, Vasopressin11
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 345 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | page 124 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | pages 86, 124, 142, 345 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | pages 86, 124, 142, 345 |
Sodium Nitrite
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.12–0.33 mL/kg | IV | not captured | standing | page 419 |
| Other | peds | 0.12–0.33 mL/kg | IV | not captured | standing | page 419 |
Sotalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 100 mg/kg | IV | not captured | standing | page 69 |
Streptokinase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 500000–1500000 unit | IV | not captured | standing | page 346 |
| Other | adult | 500000–1500000 unit | IV | not captured | standing | page 346 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI paralysis | adult | 1.5 mg/kg | IV | not captured | standing | page 240 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.25 mg | SQ | not captured | standing | page 347 |
| Asthma / bronchospasm | adult | 400 mcg | NEB | not captured | standing | page 347 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | SQ | not captured | standing | page 347 |
| Asthma / bronchospasm | peds | 0.03–0.05 mg/kg | NEB | not captured | standing | page 347 |
| Other | adult | 400 mcg | MDI | not captured | standing | page 347 |
| Other | peds | 0.03–0.05 mg/kg | not captured | not captured | standing | page 347 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | OPH | not captured | standing | page 348 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | page 349 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 349 |
| Other | adult | 100 mg | IV | not captured | standing | page 426 |
| Other | peds | 10–25 mg | IV/IM | not captured | standing | page 349 |
| Other | peds | 10–25 mg | IV/IM | not captured | standing | page 349 |
Tissue Plasminogen Activator
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 100 mg | IV | not captured | standing | pages 288, 350 |
| Other | adult | 1.25 mg/kg | IV | not captured | standing | page 288 |
| Other | adult | 100 mg | IV | not captured | standing | page 288 |
| Other | adult | 15 mg | IV | not captured | standing | page 288 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 173 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 173 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV | not captured | standing | page 351 |
Cite this
Kentucky Board of Emergency Medical Services, United States EMS Protocol Census. 339 dose entries, effective 2025-04-30.
https://protoquiz.com/census/agencies/kentucky-board-of-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.